Gestasyonel Diyabetik ve Nondiyabetik Gebelerin Glukoz, Lipid, Krom Seviyelerinin Sağlıklı Gruplara Göre Değişimlerinin İncelenmesi

Giriş ve Amaç: Bu çalışmada, gestasyonel diyabet tanısı almış ve diyabetli olmayan gebeler ile aynı yaş grubunda gebe olmayan sağlıklı kadın bireylerin Açlık Kan Şekeri total kolesterol, trigliserit ve plazma krom parametreleri çalışılarak, bu metabolik parametrelerin, gebelik ile gestasyonel diyabetteki değişimleri ve birbirleri ile etkileşimlerinin incelenmesi amaçlanmıştır. Gereç ve Yöntem: Bu çalışmaya, 50 adet gestasyonel diyabetli gebe, 50 adet diyabetli olmayan sağlıklı gebe ile 50 adet aynı yaş grubunda olan gebe olmayan sağlıklı kadın birey dahil edilmiştir. Hasta, gebe ve kontrol grubundan alınan kan örneklerinde açlık kan şekeri, total kolesterol, trigliserit ve plazma krom düzeyleri ölçülmüştür. Bulgular: Gestasyonel diyabetli grubun açlık kan şekeri ve plazma krom düzeyleri, diğer iki gruptan anlamlı yüksek çıkmıştır (p

Investigation of Glucose, Lipid, Chromium Level Changes in Gestational Diabetic and Nondiabetic Pregnants Compared with Healthy Groups

Objective: In this study, it is aimed to investigate the changes and interactions of these metabolic parameters in pregnancy and gestational diabetes and by studying fasting blood sugar, total cholesterol, triglyceride and plasma chromium parameters, in blood samples of pregnant women diagnosed with gestational diabetes, pregnant women without diabetes and healthy women who are not pregnant in the same age group. Materials and Methods: This study included 50 pregnant women with gestational diabetes, 50 healthy pregnant women without diabetes and 50 healthy non-pregnant women in the same age group. It was measured fasting blood sugar, total cholesterol, triglyceride and plasma chromium concentrations in blood samples taken from the patient and control groups. Results: Fasting blood sugar and plasma chromium levels of gestational diabetes group were significantly higher than the other two groups (p

Kaynakça

1.Turok, D.K, Ratcliffe, S.D, Baxley, E.G, Management of gestational diabetes mellitus, American Family Physician, 2003, 68, 1767-1772.

2.Harris, S.B, Caulfield, L.E, Sugamori, M.E, Whalen, E.A, Henning, B, The epidemiology of diabetes in pregnant native Canadians, a risk profile, Diabetes Care, 1997, 20, 1422-1427.

3.Mazze, R.S, Krogh, C.L, Gestational diabetes mellitus: Now is the time for detection and treatment, Mayo Clinic Proceedings, 1992, 67, 995-1002.

4.Langer, O, Yogev, Y, Most, O, Xenakis, E, M, Gestational diabetes: The consequences of not treating. American Journal of Obstetrics & Gynecology, 2005,192, 989-997.

5.Fan, Z.T, Yang, H.X, Gao, X.L, Lintu, H, Sun, W.J, Pregnancy outcome in gestational diabetes, International Journal of Gynecology & Obstetrics, 2006, 94, 12-18.

6.Moore, P, Kolterman, O, Weyant, J, Olefsky, J.M, Insulin binding in human pregnancy: comparisons to the postpartum, luteal, and follicular states. The Journal of Clinical Endocrinology & Metabolism, 1981, 52, 937-941.

7.Menato, G, Bo, S, Signorile, A, Current management of gestational diabetes mellitus, Expert Review of Obstetrics & Gynecology, 2008, 3, 73-91.

8.Takiishi, T, Gysemans, C, Bouillon, R, Mathieu, C, Vitamin D and diabetes. Endocrinology and Metabolism Clinics of North America, 2010, 39, 419-446.

9.Silverman, B.L, Rizzo, T, Cho, N, H, Metzger, B.E, Long-term effects of the intrauterine environment, The Northwestern University Diabetes in Pregnancy Center Diabetes Care,1998, 21 Suppl 2, 142-151.

10. Knowler, W.C, Barrett, Connor, E.Fowler, S.E, Hamman, R.F, Lachin, J.M, Walker, E.A, Nathan, D.M, Diabetes prevention program research g. reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, New England Journal of Medicine, 2002, 346, 393-403.

11. Lewicki, S, Zdanowski, R, Krzyzowska, M, Lewicka, A, Debski, B, Niemcewicz, M, et al, The role of chromium III in the organism and its possible use in diabetes and obesity treatment, Annals of Agrienv Medicine, 2014, 2, 331–335.

12. Davidson, I, Burt, R, Physiologic changes in plazma chromium of normal and pregnant women: Effect of a glucose load, American Journal of Obstetrics and Gynecology, 1973, 116, 601– 608.

13. Morris, B.W, Samaniego, S, Fraser, R, Macneil S, Increased chromium excretion in pregnancy is associated with insulin resistance, The Journal of Trace Elements in Experimental Medicine, 2000, 13, 389 –396.

14. Cosson, E, Benchimol, M, Carbillon, L, Universal rather than selective screening for gestational diabetes mellitus may improve fetal outcomes, Diabetes & Metabolism, 2006, 32, 140- 146.

15. Griffin, M.E, Coffey, M, Johnson, H, Universal risk factor-based screening for gestational diabetes mellitus: Detection rates, gestation at diagnosis and outcome, Diabetic Medicine, 2000, 17, 26-32.

16. Rey, E, Hudon, L, Michon, N, Fasting plazma glucose versus glucose challenge test: screening for gestational diabetes and cost effectiveness, Clinical Biochemistry, 2004, 37, 780-784.

17. Czok, R, Barthelmai, W, Enzymatische bestimmungen der glucose in blut, Wiener Klinische Wochenschrift, 1962, 40, 585- 589.

18. Norbert, W, Tietz clinical guide to laboratory tests second edition, Saunders Philadelphia USA, 1991.

19. Je, S, American Association for Clinical Chemistry Meeting Abstract, 34. Clinical Chemistry and Laboratory Medicine, 1993, 39, 1127.

20. Davis, C, M, Vincent, J, B, Isolation and characterization of a biologically active chromium oligopeptide from bovine liver, Archives of Biochemistry and Biophysics, 1997, 339, 335–343

21. Doğan A.L, Güç D, Sinyal iletimi mekanizmaları ve kanser. Hacettepe Tıp Dergisi, 2004, 35, 34-42

22. Swaroop, A, Bagchi, M, Preuss, H, G, Zafra-Stone, S, Ahmad, T, Bagchi, D, Benefits of chromium (III) complexes in animal and human health, The Nutritional Biochemistry of Chromium (III), 2019, 2, 251-278.

23. Kazi, T.G, Afridi, H.I, Kazi, N, Jamali, M. K, Arain, M.B, Jalbani, N, et al, Copper, chromium, manganese, ıron, nickel, and zinc levels in biological samples of diabetes mellitus patients, Biological Trace Element Research, 2008, 122(1), 1–18.

24. Morris, B.W, Macneil, S, Hardisty, C.A, Heller, S, Burgin, C, Gray, T.A, Chromium homeostasis in patients with type II (nıddm) diabetes Journal of Trace Elements in Medicine and Biology 1999, 13,1–2, 57-61.

25. Costello, R.B, Dwyer, J.T, Bailey, R.L, Chromium supplements for glycemic control in type 2 diabetes: limited evidence of effectiveness, Nutrition Review, 2016, 74(7), 455–468.

26. Gu, Y, Xu, X, Wang, Z, Xu, Y, Liu, X, Cao, L et al, Chromium containing traditional chinese medicine, tianmai xiaoke tablet, for newly diagnosed type 2 diabetes mellitus: a meta-analysis and systematic review of randomized clinical trials, Evidence Based Complementary and Alternative Medicine, 2018, Article ID 3708637, 8 pages

27. Houldsworth, A, Williams, R, Fisher, A, Demaine, A.G, Millward, B.A, Proposed relationships between the degree of insulin resistance, serum chromium level/bmı and renal function during pregnancy and the pathogenesis of gestational diabetes mellitus, Internatıonal Journal of Endocrınology and Metabolısm 2017, 3(1)

28. Aharoni, A, Tesler, B, Paltieli, Y, Tal, J, Dori, Z, Sharf, M, Hair chromium content of women with gestational diabetes compared with nondiabetic pregnant women, American Journal of Clinical Nutrition, 1992, 55, 104-107.

29. Ataanya, D.A, Larbie, C, The association between micronutrients levels and gestational diabetes: a cross sectional study in ashanti region, International Journal of Biochemistry Research & Review 2018, 24(2), 1-8.

30. Jovanovic, L, Gutierrez, M, Peterson, C.M, Chromium supplementation for women with gestational diabetes mellitus, The Journal Of Trace Elements İn Experimental Medicine, 1999, 12, 91–97.

31. Woods, S.E, Ghodsi, V, Engel, A, Miller, J, James, S, Serum chromium and gestational diabetes, Journal of the American Board of Family Medicine, 2008, 21, 153–157.

32. Sundararaman, P.G, Sridhar, G.R, Sujatha, V, Anita, V, Serum chromium levels in gestational diabetes mellitus, Indian Journal of Endocrinology and Metabolism, 2012, 16, 70-73.

33. Wilson, J.D, Poster, D.W, Diabetes in Williams textbook of endocrinology, 8 Baskı, WB Saunders Company, 1992, 993- 1005.

34. Hollngsworth, A.K, Endocrine and metabolic homeostasis in diabetic pregnancy, Clinics İn Perinatology, 1983, 10(3), 593– 614.

35. Hambidge, K.M, Droegemueller, W, Changes in plazma and hair concentrations of zinc, copper, chromium and manganase during pregnancy Obsterics and Gynecology, 1974, 44(5) 666-673.

36. Lain, K, Y, Catalano, P, M, Metabolic changes in pregnancy, Clinical Obstetrics and Gynecology, 2007, 50, 938-948.

37. Cefalu, W.T, Hu, F.B, Role of chromium in human health and in diabetes, Diabetes Care, 2004, 27, 2741-2751.

38. Wang Z, Q, Yu Y, Zhang X, Komoroski J, Chromium-insulin reduces insulin clearance and enhances insulin signaling by suppressing hepatic insulin-degrading enzyme andproteasome proteinexpression in kay mice, Frontiers in Endocrinology, 2014, 5, 1-6.

Kaynak Göster

  • ISSN: 2147-9607
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 2014

3.7b 2.1b